Moreover, quercetin had improved doxorubicin’s accumulation in breast cancer cells by downregulating the expression of efflux receptors, including breast Cancer Resistant Protein (BCRP), P-gp, and multidrug resistance protein 1 (MRP). The gene discussed is ABCG2; the disease is breast carcinoma.